X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

DECISION, ORDER AND JUDGMENT Presently before the Court is the application of petitioner Dustina Wiktorko, Unit Chief of the Central New York Psychiatric Center Great Meadow Correctional Facility Satellite Unit, seeking authorization to administer a medication to respondent over his objection. Respondent — who is 43 years of age — is an inmate at the Great Meadow Correctional Facility. He was convicted of kidnapping in the second degree, criminal sexual act in the first degree, and robbery in the second degree on March 9, 2010 and is currently serving a sentence of 45 years. He has been diagnosed with schizoaffective disorder, bipolar type. There have been two previous Orders granting applications to administer antipsychotic medications to respondent over his objection, which Orders covered the following time periods: (1) March 2, 2020 to March 1, 2021; and (2) October 6, 2022 to October 5, 2023. In his supporting affirmation, sworn to September 19, 2023, respondent’s treating psychiatrist — Manuel Montes de Oca, M.D. — indicates that once the most recent Order expires, respondent will stop taking his medication. Specifically, Dr. Montes de Oca indicates that respondent stated as follows: “I am doing OK, can I come off medications…I do not need it really. I get some stiffness and shakes during the night.” In the past, respondent has decompensated rapidly after stopping his medication, with Dr. Montes de Oca recounting an incident in August 2011 when respondent attempted suicide by “stab[bing] himself in the eye with a broken mop handle.” Dr. Montes de Oca further states as follows: “[Respondent's] previous [Order] expired in March 2021 and soon after that [he] stopped taking medications altogether. According to records…, [respondent] was presenting so psychotic that he was not taking care of his basic needs. His food intake became so poor that ‘technically he went on a Hunger Strike.’ He was exhibiting significant paranoia and bizarre behaviors, like eating food off the floor, urinating on the floor of his room, or defecating in the side room. His odor became so bad that it was deemed ‘unsuitable for a multi-patient living environment’ and [he] was restricted from peer interaction in the dayroom.” Respondent is currently taking Haldol, but is experiencing some tardive dyskinesia — or involuntary movements — of his mouth and tongue according to Dr. Montes de Oca, who recommends that the medication be changed to Invega Sustenna in an attempt to decrease these side effects. A hearing was held relative to this application on October 23, 2023, at which time the parties stipulated to Dr. Montes de Oca’s expertise in psychiatry and he testified as follows: “A. The evidence seems to indicate that he has a schizoaffective disorder bipolar type. That is the diagnosis basically that is in the record. “Q. And Doctor, with respect to that mental illness that you’ve just mentioned, what are Mr. F’s current symptoms? “A. He, based on my last assessment, is stable psychiatrically. “Q. And what does that mean? “A. That he is not showing significant acute mental illness” [Hearing Transcript, at p 8]. ****** “Q. Doctor, do you have an opinion, based on your care and treatment, your own evaluation and care and treatment of the patient, and your review of his progress notes and conversations that you have had with the patient, as to whether, without the medication, he would engage in conduct that is imminently likely to pose a risk of physical harm to himself or others? “A. He could be…” [Hearing Transcript, at p 21]. ****** “Q. But Mr. F is not currently showing any acute symptoms of mental illness; correct? “A. He is not showing symptoms that prompt the need to isolate, lock him or give emergency medication to him, yes” [Hearing Transcript, at p 23]. The Court found this testimony ambiguous, at times less clear and less convincing, and unusually punctuated with an injection of hearsay from others somehow involved in respondent’s care. The following is instructive: “Q. And Doctor, do you have an opinion to a reasonable degree of medical certainly, as to whether [respondent], without medication, would engage in conduct or is imminently likely to engage in conduct that poses a risk of physical harm to either himself or others? “A. Well that’s precisely the letter that I got from my supervisors on top of the Office of Mental Health. Basically they telling me, when I told them, actually I told them that I don’t think it’s going to fail, COPM scrutiny in the way he is. And they send me a letter, because basically the rule is, he is doing fine, let’s leave it alone, and when he starts showing symptoms, then we say okay, now we have to do it. But they clearly shut me up by saying, and I have it here, because his previous history of dangerous behavior…” [Transcript, at pp 19-20]. The Court ordered the parties to submit the full transcript together with proposed findings of fact and conclusions of law because the treating psychiatrist described the respondent as not currently showing any acute symptoms of mental illness, that there was no prompt need “to isolate, lock him or give emergency medication to him” [Transcript, at p 23], that he is “stable psychiatrically[, and] not showing significant acute mental illness” [Transcript, at p 8]. Petitioner’s requested relief is based upon the seminal case of Rivers v. Katz (67 NY2d 485 [1986]) (hereinafter Rivers), wherein the Court of Appeals held as follows: “[I]n situations where the State’s police power is not implicated, and the patient refuses to consent to the administration of antipsychotic drugs, there must be a judicial determination of whether the patient has the capacity to make a reasoned decision with respect to proposed treatment before the drugs may be administered pursuant to the State’s parens patriae power. The determination should be made at a hearing following exhaustion of the administrative review procedures provided for in 14 NYCRR 27.8. The hearing should be de novo, and the patient should be afforded representation by counsel. The State would bear the burden of demonstrating by clear and convincing evidence the patient’s incapacity to make a treatment decision” (id. at 497 [citation omitted]). Despite Dr. Montes de Oca’s failure to clearly and convincingly express any substantive medical opinions, the record fortuitously manages to present reliable evidence that respondent suffers with schizoaffective disorder, bipolar type and, more to the Court’s task at hand, that he lacks the capacity to make his own treatment decisions. This Court’s conclusion that the respondent lacks the capacity to determine the course of his own treatment answers only half the equation. Rivers also instructs that the Court must “determine whether the proposed treatment is narrowly tailored to give substantive effect to the patient=s liberty interest, taking into consideration all relevant circumstances, including the patient=s best interests, the benefits to be gained from the treatment, the adverse side effects associated with the treatment and any less intrusive alternative treatments. The State would bear the burden to establish by clear and convincing evidence that the proposed treatment meets these criteria” (id. at 497-498). The Court finds petitioner has established that the proposed treatment set forth in the petition is narrowly tailored to the needs of the respondent and gives substantive effect to respondent’s liberty interests. Dr. Montes de Oca also testified that the medication he was seeking to give respondent as set forth in the petition would be in respondent’s best interest because it would cause respondent to experience far fewer symptoms/side-effects than his current psychiatric medication. According to Dr. Montes de Oca, by switching respondent’s medication from Haldol to either Invega Sustenna or Abilify Maintena, respondent would experience less tardive dyskinesia and would also be at less risk of developing additional symptoms such as difficulty talking and swallowing. In fact, Dr. Montes de Oca testified that by taking respondent off the Haldol and switching him to either Invega Sustenna or Abilify, he would be less likely to have any side effects in general and would likely have a better quality of life overall. No evidence contradicts this evidence. The Court thus finds that the proposed treatment is in the respondent’s best interest. Based on the evidence before the Court, I find petitioner in her capacity as Unit Chief of Central New York Psychiatric Center’s Great Meadow Satellite Unit, has met the burden of proving by clear and convincing evidence that respondent lacks the capacity to make a reasoned decision with respect to the administration of the psychotropic medications described in the petition. I further find petitioner has demonstrated by clear and convincing evidence that the proposed treatment plan is narrowly tailored to give substantive effect to respondent’s liberty interest, considering respondent’s best interests, the benefits to be gained from the treatment, the adverse side effects associated with the treatment and any less intrusive alternatives. Therefore, having considered NYSCEF document Nos. 1, 12, 18 through 20, and a hearing having been held on October 25, 2023 with Amanda Kuryluk, Esq. appearing on behalf of petitioner and Vinson Bovier Stevens appearing on behalf of respondent, it is hereby ORDERED AND ADJUDGED that the medication proposed by Manuel Montes de Oca, M.D., and recited on pages 4 and 5 of his Evaluation, may be administered to respondent by the Office of Mental Health (OMH), or any medical practitioner authorized by OMH over his objections and in a manner determined by petitioner to be in his best interest, with assistance from the Department of Corrections and Community Supervision (DOCCS), if necessary, including DOCCS using only that degree of physical force that is lawful and reasonably necessary under the circumstances, during the care and treatment of respondent at any psychiatric satellite unit operated by OMH for the duration of one (1) year, unless respondent’s capacity is restored; and it is further; ORDERED that the file in this proceeding shall be sealed by the Washington County Clerk and shall be exhibited only to the parties to this proceeding, or to other interested parties upon further Order of the Court. The original of this Decision, Order, and Judgment has been e-filed by the Court. Counsel for petitioner is hereby directed to promptly serve a copy of the Decision, Order and Judgment with notice of entry upon the respondent in accordance with CPLR 5513. Dated: January 26, 2024

 
Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.

More From ALM

With this subscription you will receive unlimited access to high quality, online, on-demand premium content from well-respected faculty in the legal industry. This is perfect for attorneys licensed in multiple jurisdictions or for attorneys that have fulfilled their CLE requirement but need to access resourceful information for their practice areas.
View Now
Our Team Account subscription service is for legal teams of four or more attorneys. Each attorney is granted unlimited access to high quality, on-demand premium content from well-respected faculty in the legal industry along with administrative access to easily manage CLE for the entire team.
View Now
Gain access to some of the most knowledgeable and experienced attorneys with our 2 bundle options! Our Compliance bundles are curated by CLE Counselors and include current legal topics and challenges within the industry. Our second option allows you to build your bundle and strategically select the content that pertains to your needs. Both options are priced the same.
View Now
November 27, 2024
London

Celebrating achievement, excellence, and innovation in the legal profession in the UK.


Learn More
December 02, 2024 - December 03, 2024
Scottsdale, AZ

Join the industry's top owners, investors, developers, brokers and financiers for the real estate healthcare event of the year!


Learn More
December 11, 2024
Las Vegas, NV

This event shines a spotlight on how individuals and firms are changing the investment advisory industry where it matters most.


Learn More

Role TitleAssociate General Counsel, Global EmploymentGrade F13Reporting ToSenior Legal Counsel, Global EmploymentProgram/Tool/ Department/U...


Apply Now ›

Ryan & Conlon, LLP, is a boutique firm specializing in insurance defense. We are a small eclectic practice with a busy and fast paced en...


Apply Now ›

INTELLECTUAL PROPERTY PROSECUTION PARALEGAL - NEW JERSEY OR NEW YORK OFFICESProminent mid-Atlantic law firm with multiple regional office lo...


Apply Now ›